Investor & Media Relations
We discover and develop medicines to defeat neurodegeneration.
The science is breaking open and the time is right for an ambitious and rigorous effort to address Alzheimer’s disease, Parkinson’s disease, ALS and other neurodegenerative diseases. We are applying deep scientific and drug development expertise to discover effective molecular therapeutics and have engineered a proprietary technology to deliver biologic therapeutics to the brain.
With a team of experienced and passionately dedicated scientists and drug developers, we believe we can succeed in meaningfully improving the lives of patients and their families.
Corporate Presentation
- Change
- Volume
-
Market Cap
- Today's Open
- Previous Close
-
Exchange
NASDAQ
- Today's High
- Today's Low
- 52 Week High
- 52 Week Low
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Analyst Coverage
View detailed list of firms and analysts.
SEC Filing
View, download, and share all SEC Filing documents.
Corporate Governance
View, download, and share Corporate Governance documents.